DOI: 10.1055/s-00000104

Zentralblatt für Chirurgie


Reinhart K, Wiegend-Löhnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J. The MAK 195F Sepsis Study Group.
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study. 
Crit Care Med 1996; 24: 733-742  

Download Bibliographical Data

Search in: